bioRxivMicrobiology
YAP1 Activation by Human Papillomavirus E7 Promotes Basal Cell Identity in Squamous Epithelia
J. Hatterschide, P. Castagnino, H. W. Kim, S. M. Sperry, K. T. Montone, D. Basu, E. A. White
Abstract
Persistent human papillomavirus (HPV) infection of stratified squamous epithelial cells causes nearly five percent of cancer cases worldwide. HPV-positive oropharyngeal cancers harbor few mutations in the Hippo signaling pathway compared to HPV-negative cancers at the same anatomical site, prompting the hypothesis that an HPV-encoded protein inactivates the Hippo pathway and activates the Hippo effector YAP1. The HPV E7 oncoprotein is required for HPV infection and for HPV-mediated oncogenic transformation. We investigated the effects of HPV oncoproteins on YAP1 and found that E7 activates YAP1, promoting YAP1 nuclear localization in basal epithelial cells. YAP1 activation by HPV E7 required that E7 bind and degrade the tumor suppressor PTPN14. E7 required YAP1 transcriptional activity to extend the lifespan of primary keratinocytes, indicating that YAP1 activation contributes to E7 carcinogenic activity. Maintaining infection in basal cells is critical for HPV persistence, and here we demonstrate that YAP1 activation causes HPV E7 expressing cells to be retained in the basal compartment of stratified epithelia. We propose that YAP1 activation resulting from PTPN14 inactivation is an essential, targetable activity of the HPV E7 oncoprotein relevant to HPV infection and carcinogenesis.
- organism: human
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: genetic perturbation / CRISPR
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HPV18 E7 inhibits LATS1 kinase and activates YAP1 by degrading PTPN14
W. J. Blakely, J. Hatterschide, E. A. White·mBioPeer-reviewed·Oct 16, 2024
- Inactivation of the RB1 and PTPN14 tumor suppressors cooperatively enables the lifespan extension activity of the human papillomavirus E7 oncoprotein
Pushkal Sinduvadi Ramesh, Angelo A. Nicolaci, … Elizabeth A White·bioRxiv·Aug 17, 2026
- PTPN14 Degradation by High-Risk Human Papillomavirus E7 Limits Keratinocyte Differentiation and Contributes to HPV-Mediated Oncogenesis
J. Hatterschide, A. E. Bohidar, … E. A. White·bioRxiv·Nov 16, 2018
- The Anaphase Promoting Complex/ cyclosome co-activator, Cdh1, is a novel target of human Papillomavirus 16 E7 oncoprotein in cervical oncogenesis
N. Jaiswal, D. Nandi, … A. Nag·bioRxiv·Nov 5, 2021
- A conserved amino acid in the C-terminus of HPV E7 mediates binding to PTPN14 and repression of epithelial differentiation
J. Hatterschide, A. C. Brantly, … E. A. White·bioRxiv·May 22, 2020
- High-risk human papillomaviruses down-regulate expression of the Ste20 family kinase MST1 to inhibit the Hippo pathway and promote transformation
Ethan L. Morgan, Molly R. Patterson, … Andrew Macdonald·bioRxiv·Jul 14, 2018